Connection

Barbara Tilley to Clinical Trials as Topic

Back to Details
This is a "connection" page, showing publications Barbara Tilley has written about Clinical Trials as Topic.
Barbara Tilley
Connection Strength
3.460
Clinical Trials as Topic
  1. Recruitment of racial and ethnic minorities to clinical trials conducted within specialty clinics: an intervention mapping approach. Trials. 2018 Feb 17; 19(1):115.
    View in: PubMed
    Score: 0.437
  2. Enrollment of racially/ethnically diverse participants in traumatic brain injury trials: effect of availability of exception from informed consent. Clin Trials. 2014 Apr; 11(2):187-94.
    View in: PubMed
    Score: 0.334
  3. Unequal burden of disease, unequal participation in clinical trials: solutions from African American and Latino community members. Health Soc Work. 2013 Feb; 38(1):29-38.
    View in: PubMed
    Score: 0.308
  4. Secondary analyses in cardiovascular clinical trials - statistical and other considerations. Introduction. Prog Cardiovasc Dis. 2012 Jan-Feb; 54(4):329.
    View in: PubMed
    Score: 0.286
  5. Economic analysis of secondary trial data. Prog Cardiovasc Dis. 2012 Jan-Feb; 54(4):351-6.
    View in: PubMed
    Score: 0.286
  6. Retention of under-represented minorities in drug abuse treatment studies. Clin Trials. 2009 Jun; 6(3):252-60.
    View in: PubMed
    Score: 0.239
  7. Factors influencing physician referrals of patients to clinical trials. J Natl Med Assoc. 2008 Nov; 100(11):1298-303.
    View in: PubMed
    Score: 0.229
  8. Minority enrollment in Parkinson's disease clinical trials. Parkinsonism Relat Disord. 2009 May; 15(4):258-62.
    View in: PubMed
    Score: 0.226
  9. Non-linearity of Parkinson's disease progression: implications for sample size calculations in clinical trials. Clin Trials. 2005; 2(6):509-18.
    View in: PubMed
    Score: 0.176
  10. Clinical trials, outcome measures, and response criteria. J Rheumatol. 2004 Mar; 31(3):407-10.
    View in: PubMed
    Score: 0.166
  11. Communicating with participants during the conduct of multi-center clinical trials. Clin Trials. 2016 12; 13(6):592-596.
    View in: PubMed
    Score: 0.099
  12. The role of comparative effectiveness research in transfusion medicine clinical trials: proceedings of a National Heart, Lung, and Blood Institute workshop. Transfusion. 2012 Jun; 52(6):1363-78.
    View in: PubMed
    Score: 0.073
  13. A randomized recruitment intervention trial in Parkinson's disease to increase participant diversity: early stopping for lack of efficacy. Clin Trials. 2012 Apr; 9(2):188-97.
    View in: PubMed
    Score: 0.073
  14. Designing clinical trials of treatment for osteoporosis: recruitment and follow-up. Calcif Tissue Int. 1990 Dec; 47(6):327-31.
    View in: PubMed
    Score: 0.066
  15. Using global statistical tests in long-term Parkinson's disease clinical trials. Mov Disord. 2009 Sep 15; 24(12):1732-9.
    View in: PubMed
    Score: 0.061
  16. Development of a measure to assess patient trust in medical researchers. Ann Fam Med. 2006 May-Jun; 4(3):247-52.
    View in: PubMed
    Score: 0.048
  17. Optimizing the ongoing search for new treatments for Parkinson disease: using futility designs. Neurology. 2006 Mar 14; 66(5):628-33.
    View in: PubMed
    Score: 0.048
  18. Applying a phase II futility study design to therapeutic stroke trials. Stroke. 2005 Nov; 36(11):2410-4.
    View in: PubMed
    Score: 0.046
  19. Adjusting O'Brien's test to control type I error for the generalized nonparametric Behrens-Fisher problem. Biometrics. 2005 Jun; 61(2):532-9.
    View in: PubMed
    Score: 0.045
  20. Clinical trials: II. Randomization and sample size. Henry Ford Hosp Med J. 1985; 33(4):219-24.
    View in: PubMed
    Score: 0.044
  21. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke. 2003 Aug; 34(8):e109-37.
    View in: PubMed
    Score: 0.040
  22. Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS tPA stroke trial. Stroke. 2000 Oct; 31(10):2335-41.
    View in: PubMed
    Score: 0.033
  23. Myths regarding the NINDS rt-PA Stroke Trial: setting the record straight. Ann Emerg Med. 1997 Nov; 30(5):676-82.
    View in: PubMed
    Score: 0.027
  24. Pitfalls in the quest of neuroprotectants for the perinatal brain. Dev Neurosci. 2011; 33(3-4):189-98.
    View in: PubMed
    Score: 0.018
  25. Subgroup analysis of clinical trials. Am J Cardiol. 1991 Feb 01; 67(4):330-2.
    View in: PubMed
    Score: 0.017
  26. Lessons from adult stroke trials. Pediatr Neurol. 2006 Jun; 34(6):446-9.
    View in: PubMed
    Score: 0.012
  27. A responsive outcome for Parkinson's disease neuroprotection futility studies. Ann Neurol. 2005 Feb; 57(2):197-203.
    View in: PubMed
    Score: 0.011
  28. Meaningful improvement criteria sets in a rheumatoid arthritis clinical trial. MIRA Trial Group. Minocycline in Rheumatoid Arthritis. Arthritis Rheum. 1997 Mar; 40(3):419-25.
    View in: PubMed
    Score: 0.006
  29. Another look at minocycline. Bull Rheum Dis. 1996 Dec; 45(8):6-7.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.